<DOC>
	<DOCNO>NCT01380483</DOCNO>
	<brief_summary>The purpose study compare single-dose bioequivalence Par Oclassen doxycycline monohydrate , 100 mg .</brief_summary>
	<brief_title>Bioequivalence Study Doxycycline Monohydrate Tablets Under Fasting Conditions</brief_title>
	<detailed_description>To compare single-dose bioequivalence Par Oclassen ( Monodox ( R ) ) , 100 mg doxycycline fast condition .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Males , nonsmoker , 1855 year age Subjects ' weight within 15 % ideal weight base Table `` Desirable Weight Adults '' , Metropolitan Life Insurance Company , 1983 . Subjects read , sign , date Informed Consent Form prior study procedure Subjects must complete screening procedure within 28 day prior administration study medication . Clinically significant abnormality find medical screen Any clinically significant history ongoing gastrointestinal problem problem know interfere absorption , distribution , metabolism excretion drug ( e.g . chronic diarrhea , inflammatory bowel disease ) . Clinically significant illness within 4 week administration study medication . Abnormal laboratory test judge clinically significant . ECG vital sign abnormality ( clinically significant ) . History allergic reaction doxycycline relate drug ( e.g. , chlortetracycline , demeclocycline , minocycline tetracycline ) . History allergic reaction heparin . Any food allergy , intolerance , restriction , special diet opinion medical subinvestigator , contraindicate subject 's participation study . Positive urine drug screen ( see section VIII ) screen Positive test hepatitis B , hepatitis C HIV screen . Use investigational drug participation investigational study , within 30 day prior administration study medication . Recent donation plasma ( 500 mL ) within 7 day recent donation significant loss whole blood ( 450 mL ) 56 day prior administration study medication . History significant alcohol abuse within six month screen visit indication regular use two unit alcohol per day ( 1 Unit = 150 mL wine 360 mL beer 45 mL alcohol 40 % ) Recent history drug abuse use illegal drug : use soft drug ( marijuana , pot ) within 3 month screen visit hard drug ( cocaine , phencyclidine ( PCP ) , crack ) within 1 year screen visit . Subjects take prescription medication 14 day precede administration study medication counter product 7 day precede administration study medication , except topical product without systemic absorption . Subjects take drug know induce inhibit hepatic drug metabolism within 30 day prior administration study medication ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , rifampin/rifabutin ; examples inhibitor : antidepressant , cimetidine , diltiazem , erythromycin , ketoconazole , MAO inhibitor , neuroleptic , verapamil , quinidine ) . Subjects undergone clinically significant surgery 4 week prior administration study medication . Any reason , opinion medical subinvestigator , would prevent subject participate study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>bioequivalence</keyword>
	<keyword>doxycycline monohydrate</keyword>
	<keyword>fast</keyword>
</DOC>